| Kokugonza Kaijage, | |
|
7401 W Good Hope Rd, Milwaukee, WI 53223-4618 | |
| (414) 760-3273 | |
| Not Available |
| Full Name | Kokugonza Kaijage |
|---|---|
| Gender | Female |
| Speciality | Pharmacist |
| Location | 7401 W Good Hope Rd, Milwaukee, Wisconsin |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1013315084 | NPI | - | NPPES |
| 16553-40 | Other | WI | PHARMACIST LICENSE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 183500000X | Pharmacist | 16553-40 (Wisconsin) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kokugonza Kaijage, 7401 W Good Hope Rd, Milwaukee, WI 53223-4618 Ph: (414) 760-3273 | Kokugonza Kaijage, 7401 W Good Hope Rd, Milwaukee, WI 53223-4618 Ph: (414) 760-3273 |
News Archive
Mutations in RAS proteins initiate many of the most aggressive tumors, and the search for pharmacological inhibitors of these proteins has become a priority in the battle against cancer. Michail Steklov, Francesca Baietti, and colleagues from the Anna Sablina lab identified LZTR1 as an evolutionarily conserved component of the RAS pathway.
GlobalNet Services, Inc., a premier information technology provider for businesses and the Federal government, today announced that the company was awarded a $53 million contract by the U.S. Food and Drug Administration (FDA) for Web Support and Hosting Services.
Horizon Software International, the leader in K-12 food service technology and online account management, has been awarded a three-year national group purchasing contract with the Premier healthcare alliance.
Researchers at Moffitt Cancer Center have carried out a study to validate the utility of new tumor classification systems for staging and predicting relapse-free survival for patients with neuroendocrine tumors (NETs) and who may be candidates for surgery.
Pharmacyclics, Inc announced today updated results from three trials of Bruton's tyrosine kinase (BTK) inhibitor, ibrutinib (PCI-32765), for the treatment of patients with chronic lymphocytic leukemia (CLL)/small lymphocytic lymphoma (SLL).
› Verified 4 days ago
Robin L Berk, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1134 W North Ave, Third Floor, Milwaukee, WI 53205 Phone: 414-727-3005 | |
Kevin Bozymski, PHARMD, BCPS Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 1155 N Mayfair Rd, Milwaukee, WI 53226 Phone: 414-955-8950 | |
Hanna Dehnert, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3003 W Good Hope Rd, Milwaukee, WI 53209 Phone: 414-540-9236 | |
Belaynesh Dejene Feleke, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 5929 W Lisbon Ave, Milwaukee, WI 53210 Phone: 414-442-9233 | |
Ting Chen, Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3030 W Villard Ave, Milwaukee, WI 53209 Phone: 414-536-3378 | |
Matthew Olson, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 2920 W Dakota St, Milwaukee, WI 53215 Phone: 262-957-8239 | |
Michael Sean Stiewe, PHARMD Pharmacist Medicare: Not Enrolled in Medicare Practice Location: 3237 S 16th St, Milwaukee, WI 53215 Phone: 414-647-5043 |